Viewing profile — rexroad
rexroad
HN member- Joined
- Mon, Mar 16, 2026, 3:43 PM UTC
- HN karma
- 265
- Public activity
- 45 items
- HN profile
- View on Hacker News ↗
About rexroad
Recent public activity
- story
- story
-
comment
Comment #47743897
[dead]
- story
-
comment
Comment #47655848
Author here. This is Issue #6 of The American Healthcare Conundrum, a data-driven newsletter that analyzes CMS cost report data to find where U.S. healthcare dollars actually go. F…
- story
-
comment
Comment #47567421
[dead]
-
comment
Comment #47506326
[dead]
-
comment
Comment #47506300
CMS now requires hospitals to publish machine-readable price files under the Hospital Price Transparency Rule (effective 2021, enforcement added 2022). Compliance rates are technic…
-
comment
Comment #47506275
Agreed on the diagnosis: the inpatient hospital market does not function as a competitive market. Patients arriving by ambulance do not shop on price. Insurance insulates consumers…
-
comment
Comment #47506244
For-profit structure is part of the problem but not all of it. Issue 3 analyzed 3,193 hospitals using CMS HCRIS FY2023 cost reports. For-profit hospitals do have the highest cost-t…
-
comment
Comment #47506225
The direction is right. Total US healthcare spending is $4.87T for 335M people ($14,570/capita, CMS NHE 2023). Japan's per-capita is $5,790, with the highest life expectancy in the…
-
comment
Comment #47506199
[dead]
- story
-
comment
Comment #47492989
Thanks for sharing the OSU piece, good read. A few things it surfaces that complicate the "discount cards help patients" narrative: discount card companies still contract with PBMs…
-
comment
Comment #47492868
Your example captures two distinct extraction mechanisms in one transaction. The $25 to $125 gap is spread pricing: the PBM pockets the difference between what they pay the pharmac…
-
comment
Comment #47492834
[dead]
-
comment
Comment #47480794
Author here. Issue #4 is now live — pharmacy benefit managers. Three companies process 80% of US prescriptions. The FTC spent two years investigating them and documented $7.3B in s…
-
comment
Comment #47478179
The NHS prices in the Issue #2 analysis are not subsidies. They are the generic reimbursement rates from the UK Drug Tariff after patent expiry on each molecule. Apixaban (Eliquis)…
-
comment
Comment #47478156
The data supports this. The AMA's 2024 Prior Authorization survey found 93% of physicians report PA requirements delay medically necessary care. Twenty-nine percent reported a PA d…
-
comment
Comment #47478140
[dead]
-
comment
Comment #47454964
The RAND Round 5.1 study (2023) puts US commercial insurer payments at 254% of Medicare rates for identical procedures. That's the mechanism behind the international gaps — it's no…
-
comment
Comment #47454803
[dead]
-
comment
Comment #47454771
[dead]
-
comment
Comment #47454708
[dead]